Table 3.
Characteristic | Antibiotic Prophylaxis (N = 42) | Daily Symptom Monitoring Without Prophylaxis (N = 44) | P Value |
Total exposure time to index patient | .03 | ||
<10 minutes | 14 (33.3) | 9 (20.5) | |
10–29 minutes | 9 (21.4) | 24 (54.6) | |
30–59 minutes | 6 (14.3) | 4 (9.1) | |
≥1 hour | 9 (21.4) | 4 (9.1) | |
Cannot recall | 4 (9.5) | 3 (6.8) | |
Longest single interval of exposure to index patient | .93 | ||
≤5 minutes | 10 (23.8) | 9 (20.5) | |
6–10 minutes | 10 (23.8) | 11 (25.0) | |
11–20 minutes | 10 (23.8) | 14 (31.8) | |
>20 minutes | 7 (16.7) | 6 (13.6) | |
Cannot recall | 5 (11.9) | 4 (9.1) | |
Placed endotracheal, nasogastric or orogastric tube | 1 (2.4) | 3 (6.8) | .62 |
Suctioned patient, obtained sputum sample, or swabbed patient’s nose or mouth | 11 (26.2) | 6 (13.6) | .18 |
Changed respiratory tubing or administered aerosolized nebulizer therapy | 1 (2.4) | 2 (4.6) | 1.00 |
Administered oral med or fed patient by mouth | 5 (11.9) | 2 (4.6) | .26 |
Taking antibiotics at time of exposure | 1 (2.4) | 1 (2.3) | 1.00 |
Data are No. (%) of subjects.